Phase 3 efficacy and safety trial of proposed pegfilgrastim biosimilar MYL-1401H vs EU-Neulasta® in the prophylactic treatment of chemotherapy-induced neutropenia von Waller, C, Blakeley, C, Pennella, E, Bronchud, M.H, Mattano, L, Berzoy, O, Voitko, N, Adamchuk, H, Zautashvili, Z, Vinnyk, Y, Nemsadze, G, Dzagnidze, G, Shparyk, Y, Lytvyn, I, Rusyn, A, Popov, V, Láng, I, Sharma, R, Baczkowski, M, Kothekar, M

Volltext

HERITAGE: a phase III safety and efficacy trial of the proposed trastuzumab biosimilar Myl-1401O versus herceptin von Rugo, H, Barve, A, Waller, C, Bronchud, M.H, Herson, J, Yuan, J, Manikhas, A, Bondarenko, I, Mukhametshina, G, Nemsadze, G, Parra, J, Abesamis Tiambeng, M.L, Baramidze, K, Akewanlop, C, Vynnychenko, I, Sriuranpong, V, Mamillapalli, G, Ray, S, Yanez Ruiz, E.P, Pennella, E

Volltext

256 - Phase 3 efficacy and safety trial of proposed pegfilgrastim biosimilar MYL-1401H vs EU-Neulasta® in the prophylactic treatment of chemotherapy-induced neutropenia von Waller, C., Blakeley, C., Pennella, E., Bronchud, M.H., Mattano, L., Berzoy, O., Voitko, N., Adamchuk, H., Zautashvili, Z., Vinnyk, Y., Nemsadze, G., Dzagnidze, G., Shparyk, Y., Lytvyn, I., Rusyn, A., Popov, V., Láng, I., Sharma, R., Baczkowski, M., Kothekar, M.

Volltext

255 - HERITAGE: a phase III safety and efficacy trial of the proposed trastuzumab biosimilar Myl-1401O versus herceptin von Rugo, H., Barve, A., Waller, C., Bronchud, M.H., Herson, J., Yuan, J., Manikhas, A., Bondarenko, I., Mukhametshina, G., Nemsadze, G., Parra, J., Abesamis Tiambeng, M.L., Baramidze, K., Akewanlop, C., Vynnychenko, I., Sriuranpong, V., Mamillapalli, G., Ray, S., Yanez Ruiz, E.P., Pennella, E.

Volltext

8 Stem cells and growth factors: What regulates what? von Bronchud, M.H.

Volltext

The Kinetics of Human Granulopoiesis Following Treatment with Granulocyte Colony-Stimulating Factor in vivo von Lord, B. I., Bronchud, M. H., Owens, S., Chang, J., Howell, A., Souza, L., Dexter, T. M.

Volltext

Is cancer really a ‘local’ cellular clonal disease? von Bronchud, M.H

Volltext

Haemopoietic growth factors: Uses and misuses von Bronchud, M.H.

Volltext

A European perspective on haematopoietic growth factors in haemato-oncology: Report of an expert meeting of the EORTC von Croockewit, A.J., Bronchud, M.H., Aapro, M.S., Bargetzi, M.J., Crown, J., Gratwohl, A., Lange, W., Ludwig, H., Martinelli, G., Mertelsmann, R., Nuessler, V., Willemze, R., De Witte, T.J.M., Zittoun, R., Zwierzina, H.

Volltext

3.P.358 Characterization of rat smooth muscle cell lines and their subclones retrovirally transduced to produce human tumor necrosis factor-α von de Castellarnau, C., Sardá, P., Pich, I., Garcia, F., Kaubisch, A., Rosa, R., Bronchud, M.H.

Volltext

The importance of dose: Lymphomas as a model of chemosensitive malignancies von Bronchud, M.H.

Volltext

What can we expect from myeloid growth factors? von Bronchud, M.H.

Volltext

Clinical use of haematopoietic growth factors von Bronchud, M.H., Dexter, T.M.

Volltext

Book review von Bronchud, M.H.

Volltext

Book review von Bronchud, M.H.

Volltext

Haemopoietic growth factors: Unravelling the secrets of blood formation von Bronchud, M.H.

Volltext